Dow Down 0.02% Nasdaq Up 0.07%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM
0.80 Down 0.01(1.60%) 3:59PM EST
Prev Close:0.81
Open:0.82
Bid:N/A
Ask:1.25 x 400
1y Target Est:3.75
Beta:3.23
Next Earnings Date:N/A
Day's Range:0.78 - 0.83
52wk Range:0.77 - 2.54
Volume:238,361
Avg Vol (3m):215,325
Market Cap:16.92M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABIO

Comparison

Symbol% ChgMkt Cap
ABIODown 1.60%16.92M
AZNDown 0.57%93.03B
GSKUp 0.02%111.26B
ILIU 0.00%17.77M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback